IGM Total Assets from 2010 to 2024

IGMS Stock

USD 10.79 0.75 7.47%

IGM Biosciences Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 300.2 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2018-03-31

Previous Quarter

336.5 M

Current Value

304.5 M

Quarterly Volatility

160.4 M

Covid

Check IGM Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IGM Biosciences' main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Depreciation And Amortization of 8.7 M or Interest Expense of 8.3 M, as well as many indicators such as Price To Sales Ratio of 194, Dividend Yield of 0.0 or PTB Ratio of 2.25. IGM financial statements analysis is a perfect complement when working with IGM Biosciences Valuation or Volatility modules.

Check out the analysis of IGM Biosciences Correlation against competitors.

For more information on how to buy IGM Stock please use our How to Invest in IGM Biosciences guide.

Latest IGM Biosciences' Total Assets Growth Pattern

Below is the plot of the Total Assets of IGM Biosciences over the last few years. Total assets refers to the total amount of IGM Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in IGM Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. IGM Biosciences' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IGM Biosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 423.41 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

IGM Total Assets Regression Statistics

	Arithmetic Mean	148,021,455
	Geometric Mean	13,722,643
	Coefficient Of Variation	131.28
	Mean Deviation	175,612,546
	Median	1,390,000
	Standard Deviation	194,315,667
	Sample Variance	37758.6T
	Range	512.1M
	R-Value	0.83
	Mean Square Error	12552T
	R-Squared	0.69
	Significance	0.0001
	Slope	36,126,967
	Total Sum of Squares	528620.1T

IGM Total Assets History

	2024	300.2 M
	2023	423.4 M
	2022	513.5 M
	2021	298.1 M
	2020	408.6 M
	2019	261.4 M
	2018	4 M

Other Fundumenentals of IGM Biosciences

Intangibles To Total Assets

IGM Biosciences Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Capital Surpluse	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Receivables	Capital Stock
Total Assets		-0.34	0.97	-0.79	-0.8	0.7	0.95	0.65	0.95	1.0	1.0	0.98	0.87	0.71	0.89	0.96
Total Stockholder Equity	-0.34		-0.27	0.3	-0.09	-0.46	-0.15	0.07	-0.37	-0.35	-0.35	-0.38	0.02	-0.74	-0.14	-0.13
Net Tangible Assets	0.97	-0.27		-0.85	-0.72	0.8	0.94	0.5	0.98	0.97	0.98	0.97	0.79	0.75	0.86	0.94
Net Debt	-0.79	0.3	-0.85		0.48	-0.92	-0.77	-0.25	-0.87	-0.8	-0.82	-0.75	-0.57	-0.67	-0.8	-0.68
Retained Earnings	-0.8	-0.09	-0.72	0.48		-0.25	-0.89	-0.93	-0.64	-0.78	-0.76	-0.76	-0.98	-0.2	-0.9	-0.88
Accounts Payable	0.7	-0.46	0.8	-0.92	-0.25		0.66	-0.02	0.86	0.72	0.74	0.72	0.35	0.86	0.62	0.58
Capital Surpluse	0.95	-0.15	0.94	-0.77	-0.89	0.66		0.7	0.91	0.94	0.93	0.94	0.92	0.59	0.96	0.96
Total Liab	0.65	0.07	0.5	-0.25	-0.93	-0.02	0.7		0.43	0.63	0.61	0.59	0.91	0.02	0.74	0.71
Net Invested Capital	0.95	-0.37	0.98	-0.87	-0.64	0.86	0.91	0.43		0.96	0.97	0.96	0.74	0.83	0.83	0.89
Total Current Assets	1.0	-0.35	0.97	-0.8	-0.78	0.72	0.94	0.63	0.96		1.0	0.98	0.86	0.73	0.88	0.95
Net Working Capital	1.0	-0.35	0.98	-0.82	-0.76	0.74	0.93	0.61	0.97	1.0		0.98	0.84	0.74	0.87	0.94
Common Stock	0.98	-0.38	0.97	-0.75	-0.76	0.72	0.94	0.59	0.96	0.98	0.98		0.83	0.78	0.86	0.95
Property Plant Equipment	0.87	0.02	0.79	-0.57	-0.98	0.35	0.92	0.91	0.74	0.86	0.84	0.83		0.31	0.91	0.91
Current Deferred Revenue	0.71	-0.74	0.75	-0.67	-0.2	0.86	0.59	0.02	0.83	0.73	0.74	0.78	0.31		0.46	0.57
Net Receivables	0.89	-0.14	0.86	-0.8	-0.9	0.62	0.96	0.74	0.83	0.88	0.87	0.86	0.91	0.46		0.89
Capital Stock	0.96	-0.13	0.94	-0.68	-0.88	0.58	0.96	0.71	0.89	0.95	0.94	0.95	0.91	0.57	0.89

Click cells to compare fundamentals

About IGM Biosciences Financial Statements

IGM Biosciences shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although IGM Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in IGM Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on IGM Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	423.4 M	300.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for IGM Stock Analysis

When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC